Bioventus (BVS) Share-based Compensation Growth (1y) (2023 - 2025)
Bioventus (BVS) Share-based Compensation Growth (1y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | -30.44% |
| 10 | Bioventus | 831.78 Mn | 795.94 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 212.49% |
| Sep 27, 2025 | -342.79% |
| Jun 28, 2025 | 4.85% |
| Dec 31, 2024 | -734.25% |
| Sep 28, 2024 | 35.90% |
| Jun 29, 2024 | 311.46% |
| Mar 30, 2024 | 61.97% |
| Dec 31, 2023 | 116.43% |
| Sep 30, 2023 | -60.56% |
| Jul 1, 2023 | -159.19% |
| Apr 1, 2023 | -62.24% |